Adherence and Intensity of Lipid-Lowering Therapy Influences CV Risk
MONDAY, Dec. 17, 2018 -- Adherent patients receiving high-intensity statin and/or ezetimibe therapy have the lowest cardiovascular risk, according to a study published online Dec. 7 in JAMA Network Open.
Kamlesh Khunti, M.D., from the University of Leicester in the United Kingdom, and colleagues examined the correlation between adherence and treatment intensity and cardiovascular outcomes in a retrospective cohort study. Patients had documented cardiovascular disease (CVD), type 2 diabetes without CVD or chronic kidney disease (CKD), or CKD without CVD and were newly treated with their first statin and/or ezetimibe prescription between Jan. 1, 2010, and Dec. 31, 2013.
The researchers found that in the documented CVD cohort, patients receiving high-intensity therapy were more likely than those receiving low-intensity therapy to be adherent over time (84.1 versus 57.4 percent in year 1; 72.3 versus 48.4 percent in year 68). They also found a graded association with both low-density lipoprotein cholesterol reduction and CVD outcomes using a combined measure of adherence and treatment intensity: The risk was 10 percent lower for each 10 percent increase in the combined measure (hazard ratio, 0.90). The lowest risk was seen for adherent patients receiving a high-intensity regimen (hazard ratio, 0.60) compared with patients untreated for one year or longer.
"The basic message here is that long-term adherence achieves better long-term cholesterol reductions, and in turn, achieves better long-term outcomes for patients," a coauthor said in a statement.
Several authors disclosed financial ties to pharmaceutical companies, including Amgen; the study was funded by Amgen Europe GmbH.
© 2020 HealthDay. All rights reserved.
Posted: December 2018
Read this next
TUESDAY, Oct. 27, 2020 -- Most couples are concordant in cardiovascular risk factors, according to a study published online Oct. 26 in JAMA Network Open. Dov Shiffman, Ph.D.,...
TUESDAY, Oct. 27, 2020 -- Higher intake of sugary beverages and artificially sweetened beverages (ASBs) is associated with an increased risk for cardiovascular disease (CVD),...
MONDAY, Oct. 26, 2020 -- Metabolic surgery is associated with a reduced risk for major adverse cardiovascular events and death among patients with previous myocardial infarction...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.